ABSTRACT. This study was conducted to evaluate protective efficiency of three different protocols for vaccination in canine heartworm infection. To evaluate the three protocols of immunization, dogs were separately immunized with living larvae; 1) immunization with gamma-attenuated infective larvae, 2) with 50 µg/kg ivermectin-abbreviation, and 3) with chemical abbreviation plus Freund's complete adjuvant (FCA). Each group was composed of two dogs. All dogs used for this study were subcutaneously challenged with 100 intact third-stage larvae (L3) various days after the last immunization, and the worms in the pulmonary arteries and the right ventricle of the heart were recovered 17 to 25 weeks post-infection. The numbers and the sexes of the worms were determined. A mean of 38 worms was burdened in the group immunized with irradiated L3, 36 worms in the chemically-abbreviated group, but 15.5 worms in the group with chemical abbreviation plus FCA. The percentages of the protection in the former two groups were nearly 50%, but 72.3% in the group with ivermectin plus FCA. The adjuvant enhanced the protective immunity against L3 challenge. Obvious eosinophilia was observed in both immunized and control dogs except for two dogs. There was no correlation between the suppression of eosinophilia and the protective immunity in the present study. -KEY WORDS: canine, Dirofilaria immitis, immunologic protection, third-stage larvae.
dogs proliferated with canine heartworm antigens (unpublished data). Although there is normally a sufficient titer of antibody against the antigen in heartworm infection, naive dogs can not resist the infection. This escape mechanism of parasites has grounded on a mimicry theory. If parasites can decrease their surface antigens, and the hosts potentiate their immune response, the parasites will be eliminated.
On the basis of this background, studies on immunization of dogs against canine heartworm disease were carried out. It has been reported that immunization with 20-Kradattenuated L3 resulted in the resistance to the infection with D. immitis [14, 25] . Additionally, immunization with a chemically-abbreviated infection has been reported to make the ferrets and the dogs protect against the challenge infection with L3 [2, 6] . These results suggest the possibility that canine heartworm infection is protected by vaccination.
The immunization described in two previous reports [6, 25] was evaluated with minor modifications and, in addition, the enhanced efficacy of Freund's complete adjuvant was also confirmed in dogs with chemically abbreviated infection in the present study.
MATERIALS AND METHODS
Animals: Animals used in the present study were 12 male beagles purchased from Nihon Nosan Kogyo Inc. (Yokohama, Japan). The dogs were in good health, weighed between 8.5 and 10.2 kg, and their ages ranged from 24 to It has been reported that an average of approximately 50% (30.4-68.0%) [1, 7, 12, 13, 17, 19] of worms were recovered from the lung and the heart of experimentally infected dogs. However, there is no report stating that about 100% worms have been recovered; namely, half of inoculated larvae failed to migrate into the lung or the heart, and died. The decreased viability of the larvae during harvesting seemed to be one of the most appropriate reasons for the deaths. It is, however, impossible to explain why most researchers reported the recovery rates of 30.4 to 68.0% in normal animals. There is a possibility that a part of third-stage larvae (L3) that could not reach the lung or the heart were eliminated by the host defense mechanism, especially by an immune mechanism. Indeed, there has been a report stating that macaques treated with an immunosuppresant were susceptible to the infection with Dirofilaria immitis [24] .
There is a sufficient time for dogs to raise an immune response to canine heartworm, since it takes 4 months for the larvae to invade the heart and the lung [10, 11] . The host receives an adequate stimulus from the worms during this period and becomes to respond to the antigens of the worms. Actually, dogs produced antibodies to canine heartworm antigens 16 weeks after infection with L3 [8] and the peripheral blood lymphocytes from 4-week-infected 28 weeks. Prior to receiving, all were bred in mosquitoproof indoor and vaccinated against distemper virus, adenovirus type 2, and parvovirus. During the study, they were kept in mosquito-proof individual cages under a constant temperature and an illumination provided by a fluorescent lamp, automatically controlled to give a 12-hr light/dark cycle. They were fed on a standard commercial canine laboratory diet (Nihon Nosan Kogyo Inc.) once a day and offered water ad libitum throughout the study.
The present study consisted of three separate trials with the following immunization manners (Fig. 1) Co., Ltd., Osaka, Japan). Infective larvae were harvested by Baermann's method from mosquitoes at 14 or 15 days after blood meal. Briefly, the mosquitoes were anesthetized with ether vapor and collected on a gauze. The packed mosquitoes were gently crashed with a roller on a table, placed on a funnel filled up with Ringer's solution, and incubated for 1 hr at room temperature. Larvae migrating into the outer solution were collected in a fresh Ringer's solution and washed twice with Waymouth medium (GIBCO BRL, Grand Island, NY, U.S.A.) to remove the component of the crashed mosquitoes. For examining the effect of the attenuated larvae on the protection against the infection with D. immitis, the larvae were irradiated with 60 Co at a dose of 20 Krads in Waymouth medium. Dogs were subcutaneously injected with various numbers of the larvae in Waymouth medium. A 5-ml syringe attached with a 18-gauge needle was used for the injection. To make sure of injecting all worms into dogs, injection with saline was repeated twice.
Schedules of immunization and challenge infection ( The experiment traced that of Wong et al. [25] . Briefly, two dogs were immunized three times each with 500 attenuated L3 at intervals of 8 to 10 weeks. Challenge infection of four dogs with 100 intact L3 was performed 8 or 9 weeks after the last immunization.
2)Immunization with chemical abbreviation of infection (trial-2)
The experiment traced that of Grieve et al. [6] . Briefly, two dogs were infected with 500 intact L3, and then given ivermectin (CARDOMEC 136, Produced by Merck, Sharp and Dome Ltd., NJ, U.S.A. and distributed by Dainippon Pharmaceutical Company, Ltd., Osaka, Japan) at an oral dose of 48 to 57 µg/kg 8 or 9 weeks after infection. Two control dogs were also treated with this drug at the same dose and by the same schedule. At an interval of 4 or 5 weeks, this schedule was repeated three times. Challenge infection was given to four dogs with 100 intact L3 at 4 weeks after the last ivermectin administration.
3)Immunization with chemical abbreviation plus Freund's complete adjuvant (trial-3)
To shorten the duration of the experiment, the above schedule and manipulation were modified. Briefly, two dogs were infected with 500 intact L3, and simultaneously injected at another site with an emulsion of Freund's complete adjuvant (FCA; DIFCO Laboratories, Detroit, MI, U.S.A.). FCA was mixed with the same volume of saline, sonicated at a maximal power, and the emulsion was suspended in saline containing 2% Tween 80 with a sonicator. Finally, the adjuvant formed water-in-oil-in water. The preparation in 0.8 ml, equivalent to 0.3 ml of FCA, was injected into the back skin of the immunized dogs in eight divided doses. At an interval of 6 weeks, this regimen was repeated twice. Two weeks after the second regimen, all four dogs were medicated with ivermectin at an oral dose of 58 to 62 µg/kg, then challenge infection was accomplished in the same way as above.
To confirm the humoral immune response in all immunized dogs, serum antibody was titrated a few days before the challenge infection by antibody-capture enzymelinked immunosorbent assay.
Recovery of adult worms: To count the worms migrating into the heart and the pulmonary arteries, all animals were killed with an intravenous administration of sodium pentobarbital at a dose of 60 mg/kg. Immediately after the heart beats had stopped, they were necropsied and the right ventricle of the heart and the lung were examined in detail. Recovered worms were kept in saline until counting and determining the sexes of the worms. Effectiveness of the immunization was calculated with the following formula: % protection = [Mean worm recovery from control dogs worm recovery from the immunized dog] / mean worm recovery from control dogs.
Eosinophil counts: At monthly intervals, samples of the venous blood were drawn from every dog. Eosinophils were counted from the percent eosinophils in a differential count multiplied by the total white blood cell count.
Enzyme-linked immunosorbent assay: Antibody-capture enzyme-linked immunosorbent assay (ELISA) was performed with immunized canine sera. Wells of a microplate (Flow Laboratories, Costa Mesa, CA, U.S.A.) were coated with D. immitis antigen in 0.1 M carbonate buffer (pH 9.6). Sera diluted 1:100 were placed in the wells and incubated for 1 hr at 37°C. After three washes, appropriately diluted anti-canine IgG antibody conjugated with peroxidase was added to the wells and incubated again in the same way as above. After free conjugated antibody was washed away, 2,2'-azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid) (Sigma Chemicals, Saint Louis, MO, U.S.A.) at a concentration of 0.3 mg/ml, and 0.01% peroxide as a substrate were added to the wells. The plate was placed for about 20 min at room temperature and 1% sodium dodecyl sulfate (SDS; Wako Pure Chemical Industries, Ltd., Osaka, Japan) solution was added to the wells to stop the reaction. The absorbance was read with a microplate reader. ELISA values were calculated with the following formula: ELISA value = (Sample absorbance the absorbance of the negative control) / (the absorbance of the positive control the absorbance of the negative control) × 100. Antigen for ELISA: Adult worms were collected from naturally infected dogs and stored at 40°C until processing for the antigen preparation. The worms were lyophilized and crashed with a mortar and a pestle. The minute fragments of the worms were rehydrated in 0.01 M phosphate buffered saline (PBS; pH 7.0) and sonicated on ice until the cuticle was separated from the inner structures.
The preparation was washed with PBS, centrifuged for 1 hr at 10,000 × g until the protein in the supernatant disappeared. The sediments were resuspended in 0.05 M Tris-HCl buffer (pH 5.6) containing 1% SDS and 5% betamercaptoethanol (Sigma Chemicals) and sonicated for 15 min on ice. The homogenate was extracted overnight at 4°C and centrifuged for 1 hr at 10,000 × g at 4°C. This supernatant was dialyzed against 0.01 M PBS for three days and centrifuged for 1 hr at 10,000 × g at 4°C to remove the precipitate. The supernatant was used for ELISA after determining protein concentration in the supernatant with Bradford's method. (Table 1) Eosinophil Counts (Fig. 2 ): 1) Immunization with attenuated L3 (trial-1) Eosinophilia was uncertain during the immunization in all dogs but dog B that showed a slight eosinophilia immediately before challenge infection. Although eosinophilia in dog B disappeared in 8 weeks after the infection, the other three showed a prominent elevation of eosinophil counts in 10 weeks or 17 weeks after the infection. All dogs recovered from eosinophilia in 21 or 22 weeks after the infection.
RESULTS

Recovery of Adult Worms
2) Immunization with chemical abbreviation of infection(trial-2)
Eosinophil counts did not change significantly throughout immunization, but mild eosinophilia appeared in 13 weeks after the challenge infection in three of the four animals.
3) Immunization with chemical abbreviation plus Freund's complete adjuvant (trial-3)
During immunization, the number of eosinophils did not exceed the upper limit of the normal range. However, severe eosinophilia was recognized in control dogs in 15 weeks after the infection. In 17 weeks, these eosinophil counts dropped but still remained high. In immunized dogs, the counts slightly elevated at 15 weeks. The eosinophil count of a dog (dog J) restored the normal range at 17 weeks after the infection, but that of the other increased. In immunized and control dogs, the suppression of eosinophilia was unrelated to the intensity of the protection from the infection. ELISA ( Table 2) : The ELISA values, prior to the immunization and the challenge infection in the immunized dogs, are shown in Table 2 . Before the first immunization, ELISA values of five dogs in the immunized groups were lower than the negative control level. Only dog J had a value of 1.79. Then, in every dog immunization was finished; a few days before the challenge infection, their values were between 26.6 and 99.5. Dog F indicated a lower ELISA value than did the others.
DISCUSSION
To conduct a further study that focuses on the analysis of the mechanisms of the protection from L3 challenge infection in immunized dogs, the authors first followed the protocols described by Wong et al. and Grieve et al. with lesser modifications [6, 25] (trial-1 and -2). Although their results showed approximately 100% protection against L3 of D. immitis in dogs, in the present study, the average protections were 42.0% for the immunization with gammaa t t e n u a t e d L 3 a n d 5 1 . 7 % f o r t h a t w i t h ivermectin-abbreviation. In comparison with the previous values described by them, our results were only half.
According to Wong et al. [25] , the dogs immunized with gamma-attenuated L3 perfectly resisted the challenge infection with intact L3 only at approximately 90 days after the latest immunization, but at 57 or 120 days postimmunization, the protection reduced. This suggests that there is an optimal period from immunization to infection and the period is very short. However, Grieve et al. [6] has reported that dogs immunized with the abbreviation of the L3 infection were completely protected against the double challenge infections 156 and 212 days after the last administration with ivermectin except one of four dogs. The duration from the last killing to the challenge was obviously longer than the optimal period described by Wong et al. [25] . Thus, the period is not seemed to be so important.
A total of 1,500 L3 worms was used for the immunization of one dog in trial-1 and -2. This number of worms may be enough to develop immunity in dogs, since high antibody titers were demonstrated by ELISA in immunized dog sera before the challenge infection. Additionally, dog F showed a relatively lower titer in the serum than did the others at this time, but there was no difference in the recovery rate of the worms among these immunized animals. The ELISA values do not explain the intensity of the protection, but do show adequately the immunized dogs responding to the immunization performed by the authors.
The recovery rates in control dogs must be reflected by the viability of infective larvae used for the challenge infection. Their recovery rates in nonimmunized dogs were 22-54 and 31-40% described by Wong et al. and Grieve et al., respectively [6, 25] . These rates were distinctly lower than those of the authors. In the experimental infection, the authors usually eliminated immotile larvae, but were not able to separate mildly damaged worms from those used for the challenge infection. The cryptic damage of the larvae may affect the molt coming soon after injection and their survival in immunized dogs, and the damaged worms must be easily eliminated during the migration without regard to the intensity of immunity of dogs. Thus, the low viability of the larvae may produce higher percentage of the protection than the truth. On the other hand, adult worm recovery from immunized dogs with gamma-attenuated L3 fluctuated between 34% and 97% [14] . The wide fluctuation indicates that the dogs did not uniformly respond to the challenge in accordance with the immunization protocol. Because, the authors used out-bred beagles for the present study, and there was no information of genetic backgrounds of the dogs related to immune response. These immunization protocols may have a problem in the reproducibility of inducing the protective immunity. The experiments in trial-1 and -2 took 45 and 64 weeks from the first immunizations to necropsies, respectively. The authors considered an immunologic enhancement to shorten the period of experiment and to improve the protection. To stimulate further the immune system with excretory and secretory antigens, molt-related antigens, and dead worms, Freund's complete adjuvant (FCA) was simultaneously administered with L3 injection for immunization in trial-3 (Table 1 ). Reduced recovery of adult worms was observed by adding FCA administration to the protocol of trial-2. FCA has widely been used to enhance immune responses. The complete adjuvant that includes Mycobacterium tuberculosis potentiates the activation of macrophages and consequently enhances both antibody production and cell-mediated immunity [3] . It is important to activate the effectors even if the larvae are eliminated by the antibody-dependent cell-mediated immunity as the microfilariae [16, 23] . There are reports mentioning the correlation between the presence of anticuticular antibody and impairment of L3 growth and motility in the system of Dipetalonema viteae and rodents [4, 20, 21] . Resistance to the infective larvae of Brugia pahangi has occurred by the T cell-dependent mechanism [18, 22] . The authors have proved that cell-mediated immunity rather than antibody [9] , especially macrophages, is important for mice to protect against L3 of Brugia malayi. Macrophages are activated also by T helper 1 (Th1) cytokines [5, 15] produced by T lymphocytes and itself. In the present study, adding FCA is thought to stimulate Th1, even though those dogs showed eosinophilia that is induced by T helper 2 cytokine such as interleukin 5. The authors did not recognize any correlation between the intensity of the protection and the suppression of eosinophilia.
It has been reported that microfilariae of D. immitis were eliminated from the peripheral blood with antibody against their surfaces in occult dogs [26] . Conversely, in L3 infection, antibody against D. immitis may not play an important role in protection of dogs; because, even though high antibody titer was kept in the peripheral blood during the tissue migration of D. immitis in its host [27] , nearly 50% of the worms experimentally infected have been recovered from the heart and the pulmonary arteries. However, the mechanism of the protection has not yet been explained.
